Broad-Spectrum Kinome Profiling Identifies CDK6 Upregulation as a Driver of Lenvatinib Resistance in Hepatocellular Carcinoma

Scientists employed a lysine-targeted sulfonyl fluoride probe, named XO44, which bound to 133 endogenous kinases in intact lenvatinib-resistant HCC cells.